Skip to content
Forge Biologics
  • About
    • About
    • Mission & Approach
    • Leadership
    • Board
  • Services
    • Manufacturing Services
    • Technology
  • Science
    • Science
    • Pipeline
    • About Gene Therapy
    • FBX-101 for Krabbe Disease
  • Careers
  • News & Insights
    • News
    • Events
    • Insights
    • Media Kit
  • Connect

FBX-101 and the RESKUE Trial: Exploring AAV-Based Gene Therapies for Krabbe Disease

Posted on April 15, 2022 (June 1, 2022) by Forge Biologics
0/5 (0 Reviews)
Posted in Biologics News, Podcast

Post navigation

 Forge Biologics to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing SummitForge Biologics shares plans for growth at Meeting on the Med 
Copyright Forge Biologics - All Rights Reserved Cookie Notice | Privacy Policy

I agree to the Cookie Notice and Privacy Policy

I agree